Pharma’s Green Revolution: Sustainable Practices in Drug Manufacturing Kumar Jeetendra | December 6, 2024 Amidst the number of industries showing interest in practicing sustainability, the pharmaceutical sector is also not lagging behind. The industry is in the process of change as a result of environmental concerns, regulatory needs, and increasing consumer knowledge. This transformation in drug manufacturing has been labeled as the Green Revolution—where new emerging practices mean that …
PHARMA STABILITY & IMPURITY TESTING :Securing Quality from Lab to Market Kumar Jeetendra | September 1, 2025 Within the pharmaceutical arena, the promise of medicine always rests on scientific assurances of safety, efficacy, and uniformity. Every dosage form—pills, injectables, or capsules—emerges from an equally demanding program of stability and impurity testing, two safeguards that oversee quality as metabolically as any dose itself. The Justification for Stability Studies Stability testing quantifies the shelf-life …
Why Bioguard is essential to stay compliant without stopping production Kumar Jeetendra | March 5, 2026 QA/QC heads face an impossible choice: enforce contamination control and face pushback, or cut corners and risk regulatory fines. Traditional disinfection forces this trade-off; Bioguard doesn’t. That’s majorly because Indian pharmaceutical manufacturers are standing at a critical crossroad. FDA warning letters hold steady at 23 per year [1], contamination violations are up 25% since 2014 …
